期刊文献+

吉兰-巴雷综合征相关抗神经节苷脂抗体研究进展 被引量:12

下载PDF
导出
摘要 吉兰-巴雷综合征(Guillian—Barre’Sydrome,GBS)是继脊髓灰质炎后引起人类迟缓性瘫痪的常见原因,多为四肢对称性无力,腱反射减弱或消失,发病后1~2w腰穿检查可见蛋白-细胞分离。GBS的发病机制目前尚不明确,但大部分学者认为前驱感染的细菌和病毒与人类周围神经的神经节苷脂结构类似,通过分子模拟机制致病,
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第12期1133-1135,共3页 Journal of Apoplexy and Nervous Diseases
  • 相关文献

参考文献24

  • 1束晓梅,蔡方成.吉兰-巴雷综合征与神经节苷脂抗体[J].国外医学(神经病学.神经外科学分册),2004,31(6):525-528. 被引量:2
  • 2Islam Z, Jacobs BC, van Belkum A, et al. Axonal variant of Guillain- Barre syndrome associated with Campylobacter infection in Bangla- desh[ J]. Neurology,2010,74(7) :581 -587. 被引量:1
  • 3Kaida K, Kusunoki S. Antibodies to gangliosides and ganglioside complexes in Guillain-Barre syndrome and Fisher syndrome: mini-review [ J ]. J Neuroimmunology,2010,223 ( 1 ) :5 -'12. 被引量:1
  • 4Susuki K, Nishimoto Y, Yamada M, et al. Acute motor axonal neuropa- thy rabbit model:immune attack on nerve root axons [ J ]. Ann Neurol, 2003,54(3) :383 -388. 被引量:1
  • 5Phongsisay V, Susuki K, Matsuno K, et al. Complement inhibitor pre- vents disruption of sodium channel clusters in a rabbit model of Guil- lain-Barre syndrome [ J ]. J Neuroimmunol,2008,205 ( 1 ) : 101 - 104. 被引量:1
  • 6Yuki N, Kuwabara S. Axonal GuiUain-Barre syndrome:carbohydrate mimicry and pathophysiology [ J ]. J Peripheral Nervous System,2007, 12(4) :238 -249. 被引量:1
  • 7Ho TW,Willison HJ,Nachamkin I,et al. Anti-GDla antibody is asso- ciated with axonal but not demyelinating forms of Guillain-Barre syn- drome [ J ]. Ann Neurol, 1999,45 : 168 - 173. 被引量:1
  • 8YuKi N, Ang CW, Koga M, et al. Clinical features and response to treatment in Guillain-Barre syndrome associated with antibodies to GM 1 b ganglioside [ J ]. Ann Neuro1,2000,47:314 - 321. 被引量:1
  • 9Yuki N. Ganglioside mimicry and peripheral nerve disease[ J]. Muscle Nerve,2007,35 (6) :691 -711. 被引量:1
  • 10Mori M, Kuwabara S, Yuki N. Fisher syndrome : clinical features, im- munopathogenesis and management [ J ]. Expert Review of Neuro Therapeutics,2012,12 ( 1 ) :39 - 51. 被引量:1

二级参考文献20

  • 1Hugh J, Willison, Nobuhiro Yuki. Peripheral neuropathles and antiglycolipid antibodies. Brain, 2002, 125(Pt 12) : 2591 - 2625. 被引量:1
  • 2Griffin J-W, Li CY, Ho TW, et al. Pathology of the motor - sensory axonal Guillain-Barre syndrome. Ann. Neurol, 1996, 39: 17-28. 被引量:1
  • 3Chowdhury D, Arora A. Axonal Guillain - Barre syndrome: a critical review. Acta Neural Scand, 2001, 103: 267-277. 被引量:1
  • 4Haler- Macko CE, Sheikh KA, Li CY, et al. Immune attack on the Schwann c~ll surface in acute inflammatory demyelinatingpolyneuropathy. Ann Neurol, 1996, 39: 625- 635. 被引量:1
  • 5Ang CW, Tio - Gillen AP, Groen J, et 8]. Cross - reactive anti galactocerebroside antibodies and Mycoplasma pneumoniae infections in C, uillain - Barre syndrome. J Neuroimmunol, 2002, 130( 1- 2) : 179- 183. 被引量:1
  • 6Handmwa H, Utsumi H, Asano A, et al. Anti - LMI antibodies in the sera of patients with Guil]aln - Barre syndrome, Miller Fisher syndrome,and motor neuron disease. J Peripher Nerv Syst, 2002, 7( 1): 54-58. 被引量:1
  • 7Yuki N. Infectious origins of, and molecular mimicry in, GuillainBarre and Fisher syndromes. Lancet IrJect Dis, 2001, 1(1): 29-37. 被引量:1
  • 8Schwerer B. Autoantlbodies against gangliosides GMI and GQIb,charactm'istic cell sudace glycolipids of the nervous system, are present in specific clinical types of GuillainBane syndrome. Microbes Infect,2002, 4(3) : 373 - 384. 被引量:1
  • 9Press R, Mata S, Lolli F, et al. Temporal profile of anti - ganglieside antibodies and their relation to clinical parameters and tnmtment in CuillainlnBarre syndrome. J Neurol Sci, 2001, 190: 41 -47. 被引量:1
  • 10Griffin JW, Li CY, Maeko C, et al. Early nodal change in the acute motor axona] neuropathy pattern of the Guil]ain Barre syndrome. J Neuroeytol, 1996, 25: 33-51. 被引量:1

共引文献1

同被引文献59

  • 1张在强.抗糖脂抗体与周围神经病[J].继续医学教育,2006,20(6):5-8. 被引量:2
  • 2吴磊,吴卫平,黄德晖,徐全刚,蒲传强.Miller-Fisher综合征和Bickerstaff脑干脑炎的临床特点及鉴别诊断[J].临床神经病学杂志,2007,20(2):84-86. 被引量:22
  • 3陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33. 被引量:501
  • 4McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance[J]. FEMS Microbiol Rev, 2002,26 (1) : 91-107. 被引量:1
  • 5Perez-Velez CM,Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease:a diagnostic challenge [J].Clin Infect Dis,2007,45(8):950-957. 被引量:1
  • 6Wang SM, Liu CC. Enterovirus 71 : Epidemiology, pathogenesis and management [J]. Expert Rev Anti Infect Ther, 2009,7(6) : 735-742. 被引量:1
  • 7Isselbacher K J, Braunwald E, Wilson JD. Harrison's principles of internal medicine [M]. 2 ed. New York: Me Graw-Hill Book Company, 1994 : 128. 被引量:1
  • 8Wang SM,Lei HY, Huang MC, et al. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis[J]. J Clin Virol, 2006 , 37 (1) :47-52. 被引量:1
  • 9Cao R, Han J, Deng Y, et al. Presence of high-titer neutralizing antibodies against enterovirus 71 in intravenous immunoglobulin manufactured from Chinese donors [J].Clin Infect Dis,2010,50(1):125-126. 被引量:1
  • 10Kaneko Y, Nimmerjahn F, Ravetch JV. Anti inflammatory activity of immunoglohuiin G resulting from Fc sialylation [J]. Science, 2006,313 (5787) : 670-673. 被引量:1

引证文献12

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部